Vikram Sudarsan

Biography

 Vikram is a versatile biotech pharma professional with deep expertise in the scientific and commercial aspects of drug development. Prior to joining Cipla, Vikram helped start IMS's new Transaction Advisory Practice – IMS Health Capital, Inc. as an Engagement Manager in Partnership. Prior to that Vikram helped establish and grow the Asset Valuation practice at PriceSpective, LLC before its sale to ICON Plc. At IMS and PriceSpective he built a differentiated risk-sharing based licensing, mergers & acquisitions business. He led global teams to develop a deep understanding of assets value and potential before advising clients on transactions. Vikram has led due diligence projects for several of the top twenty pharma companies on the buy-side and strategy development projects for numerous small biotech clients on the sell-side. Vikram is an INLAKS scholar. He has a PhD in genetics from University of Sheffield, UK and carried out his doctoral research at the University of Cambridge. He has a Post Doctorate in Neurobiology from Stanford University Howard Hughes Medical Institute. He has a B.Sc in Biology from St Joseph's College, Bangalore University and an M.Sc in Biochemistry from MS University Baroda.    

Research Interest

 Genetics and Biology